TP53 and neoplasm: All but one tumour assigned as p53 IHC normal were TP53 wild-type (16/17; agreement: 94.1%), and all but two tumours evaluated as p53 IHC abnormal in the consensus were TP53-mutant (21/23; agreement: 91.3%).